JCR Pharmaceuticals Co., Ltd. (JCR) will contribute to the development of a sustainable society through business activities based on its corporate philosophy of “Contributing towards people’s healthcare through pharmaceutical products.”
Since its inception in 1975, JCR has sought to create groundbreaking therapeutics that respond to unmet medical needs, particularly in the rare diseases field, under its corporate philosophy of “Contributing towards people’s healthcare through pharmaceutical products.” To this end, we have been harnessing forward-looking biotechnologies, as well as technologies for cell therapy and regenerative medicine.
The global environment and conditions and issues facing society have been changing year by year. With this in mind, JCR believes that it is crucial to create sustained corporate value through its business activities, while contributing to the development of a sustainable society. As a reliable pharmaceutical company contributing to the welfare of society, we will proactively implement activities in the core areas of Rare Diseases (RD), Environment (E), Society (S), and Corporate Governance (G).
JCR believes that partnership and cooperation with the international community are the most important priorities for realizing sustainability.
Going forward, JCR will link its activities to the 17 goals laid out in the SDGs, in keeping with the spirit of “No one will be left behind.” It will share with and return the achievements of these efforts to a wide range of stakeholders.